CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 8-K Event Results of operations · Other events
- 424B5 Offering Prospectus
- 4 Open-market sale Chief Financial Officer sold 1,568 shares at $78.27 ($122,727)
- 8-K Event Executive or director change · Other events
- 424B7 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale EVP/Chief Scientific Officer sold 10,000 shares at an average $63.22 ($632,156)
- 4 Open-market sale EVP/Chief Scientific Officer sold 10,000 shares at $45.00 ($450,000)
- 4 Open-market sale EVP/Chief Scientific Officer sold 20,000 shares at $40.02 ($800,400)
- 4 Grant or award EVP/Chief Medical Officer acquired 20,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP/Chief Scientific Officer sold 228 shares at $31.21 ($7,116)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale EVP/Chief Scientific Officer sold 3,000 shares at $31.39 ($94,170)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale CEO sold 1,976 shares at $36.66 ($72,440)
- 4 Open-market sale EVP/Chief Scientific Officer sold 10,000 shares at $35.29 ($352,900)
Page 19 of 37 · 731 filings